The Institute is an independent charitable life sciences institute, sponsored by the Biotechnology and Biological Sciences Research Council.
|Telephone:||01223 496 000|
|Address:||Babraham Hall, Babraham Research Campus, Babraham|
|Membership type:||Cambridge University Department|
The Institute undertakes world-leading, innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities. The commercialisation of the Institute's research is managed by its wholly-owned trading subsidiary, Babraham Institute Enterprise (BIE).
Professor Wolf Reik, Associate Director and Head of the Epigenetics research programme at the Babraham Institute has been awarded a Wellcome Trust Investigator Award for research into how to reprogramme the epigenome. The Award provides £2.6 million in funding for five years. Research funded by the award will commence in October this year and involve the recruitment of three new research positions to the Reik lab.
12 July 2018Read in full
A group of genes and genetic switches involved in age-related brain deterioration have been identified by scientists at the Babraham Institute, Cambridge and Sapienza University, Rome.
5 March 2018Read in full
A multi-disciplinary team of scientists, including Professor Wolf Reik from the Babraham Institute, has been shortlisted to the final stages of Cancer Research UK's Grand Challenge* – an ambitious series of £20m global grants tackling some of the toughest questions in cancer research.
8 February 2018Read in full
A team of Cambridge researchers led by scientists at the Babraham Institute have discovered the hidden connections in our genomes that contribute to common diseases.
21 November 2016Read in full
A bit like someone looking into a mirror reflected in another mirror, as one new life is developing as an embryo, the capacity to produce the next generation of life is already being established in that embryo.
10 October 2016Read in full